Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for CBD Cannulation Time in ERCP
NCT05945797Completed
- Sponsor
- Gujranwala Medical College District Headquarters Hospital
- Start
- Aug 2023
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial comparing Dexamethasone Group with Placebo Group (2 arms). Primary endpoint: Shortening of CBD cannulation time at 30 minutes. Started Aug 2023; status: completed.
02
Drugs
dexamethasone
Beyond the preview
Go deeper on NCT05945797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05945797.